– USA, NJ – Johnson & Johnson (NYSE: JNJ) today announced the election of its CEO, Joaquin Duato, to the additional position of Chairman of the Board of Directors, effective in January 2023, to succeed Alex Gorsky, who will step down from his role as Executive Chairman.
“Joaquin’s appointment to the additional role of Chairman reflects his tremendous 30-year track record at Johnson & Johnson, as well as the Board’s thoughtful and engaged approach to succession planning. During Joaquin’s career with the Company, the Board has witnessed firsthand his ability to effectively lead, collaborate, and create value for all our stakeholders. We have the utmost confidence that he will continue to be an excellent steward of the business and look forward to working closely with him in this next chapter,” said Lead Independent Director, Anne Mulcahy.
About Joaquin Duato
Joaquin Duato has served as Johnson & Johnson’s CEO and a member of the Board of Directors since January 3, 2022. Before that time, he held senior leadership positions over his 30-plus-year career with the Company across multiple business sectors, geographic, and functions.
Mr. Duato said, “Guided by our Credo, I will continue to work closely with the other Directors to build on Johnson & Johnson’s success. I also want to thank Alex for his countless contributions to our Company. He has inspired an entire generation of leaders with his passion for improving human health, built the best team in the industry, and laid a strong foundation for the future of both Johnson & Johnson and Kenvue, the planned new Consumer Health company.”
Joaquin Duato is CEO of Johnson & Johnson and serves on its Board of Directors. He leads a global workforce of 135,000 employees in developing and delivering transformational and innovative healthcare solutions in Pharmaceuticals, MedTech, and Consumer Health. Previously, Joaquin served as Vice-Chairman of the Executive Committee, where he provided strategic direction for the Pharmaceutical and Consumer Health sectors and oversaw both Information Technology and the Global Supply Chain.
A believer in the power of technology to accelerate progress in healthcare, Joaquin is leading Johnson & Johnson to harness data science and intelligent automation to solve the world’s toughest health challenges. He is committed to building an inclusive workforce that reflects the patients Johnson & Johnson serves.
He earned an MBA from ESADE in Barcelona, Spain, and a Master of International Management from Thunderbird School of Global Management in Phoenix, Arizona.
About Johnson & Johnson
At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities, and forward progress. That’s why for more than 135 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest diversified healthcare products company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body, and environment within reach of everyone, everywhere. We are blending our heart, science, and ingenuity to change the trajectory of health for humanity profoundly.
For more information: https://www.jnj.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
